121 related articles for article (PubMed ID: 1973460)
1. Do we need a new classification of beta-blockers?
Kendall MJ
J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
[TBL] [Abstract][Full Text] [Related]
2. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
Barrett AM
J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
Wallin JD; Shah SV
Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of third-generation beta-blockers: greater benefits, fewer risks.
Kendall MJ
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S4-8. PubMed ID: 2481789
[TBL] [Abstract][Full Text] [Related]
6. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
Stoschitzky K; Lindner W
Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
[TBL] [Abstract][Full Text] [Related]
7. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
Koebe P; Rost R; Reinke A; Nagel N; Merten U
Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
[TBL] [Abstract][Full Text] [Related]
8. Comparative properties of various beta-blockers, with an outlook to the future.
van Zwieten PA
Clin Physiol Biochem; 1990; 8 Suppl 2():18-27. PubMed ID: 1982758
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
Weir MR
Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
Shand DG
Circulation; 1983 Jun; 67(6 Pt 2):I2-5. PubMed ID: 6133642
[TBL] [Abstract][Full Text] [Related]
11. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative treatment with beta-receptor blockers and isoflurane anesthesia. Hemodynamic interactions in patients with coronary disease].
Eichwede F; Komar K; Müller R; Grote B; Tarnow J
Anaesthesist; 1990 Jul; 39(7):361-6. PubMed ID: 1974748
[TBL] [Abstract][Full Text] [Related]
13. [Do beta-blockers prevent coronary events in hypertensive patients?].
Diévart F; Ragot S; Julien J; Herpin D
Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of heart failure with beta-blockers?].
Osterziel KJ; Dietz R
Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
[TBL] [Abstract][Full Text] [Related]
15. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in hypertension.
Hansson L
J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
[TBL] [Abstract][Full Text] [Related]
18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
19. [Secondary prevention of myocardial infarct with beta blockers].
Vacheron A; Baubion N; Delage F
J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment.
Dahlöf C; Dimenäs E; Kendall M; Wiklund I
Circulation; 1991 Dec; 84(6 Suppl):VI108-18. PubMed ID: 1683605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
